{"log_id": 2434361913217919592, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0, "average": 0.997244, "min": 0.997244}, "location": {"width": 22, "top": 171, "height": 22, "left": 1160}, "words": "品"}, {"probability": {"variance": 0.01919, "average": 0.94528, "min": 0.554188}, "location": {"width": 166, "top": 233, "height": 24, "left": 231}, "words": "宰无MAO抑制活性"}, {"probability": {"variance": 0, "average": 0.980088, "min": 0.980088}, "location": {"width": 30, "top": 204, "height": 63, "left": 1158}, "words": "准"}, {"probability": {"variance": 3e-06, "average": 0.998369, "min": 0.995537}, "location": {"width": 81, "top": 279, "height": 23, "left": 231}, "words": "毒理研究"}, {"probability": {"variance": 0, "average": 0.999739, "min": 0.999475}, "location": {"width": 83, "top": 325, "height": 25, "left": 230}, "words": "遗传毒性"}, {"probability": {"variance": 0.007862, "average": 0.975365, "min": 0.426205}, "location": {"width": 733, "top": 367, "height": 29, "left": 281}, "words": "文拉法辛及O去甲基文拉法辛Ames试验、 CHO/HGPRT哺乳动物细胞正向基因突变试"}, {"probability": {"variance": 0.004496, "average": 0.97366, "min": 0.6264}, "location": {"width": 760, "top": 413, "height": 31, "left": 232}, "words": "验结果均为阴性。文拉法辛 BALB/c-3T3小鼠细胞转化试验、CHO细胞姐妹染色体交换试验"}, {"probability": {"variance": 0.006032, "average": 0.982756, "min": 0.502484}, "location": {"width": 780, "top": 457, "height": 32, "left": 233}, "words": "大鼠微核试验结果均为阴性。0去甲基文拉法辛CHO染色体畸变试验结果为阴性,大鼠微"}, {"probability": {"variance": 9.8e-05, "average": 0.995882, "min": 0.969725}, "location": {"width": 158, "top": 508, "height": 24, "left": 233}, "words": "核试验结果为阳性"}, {"probability": {"variance": 0, "average": 0.999518, "min": 0.998843}, "location": {"width": 79, "top": 553, "height": 24, "left": 234}, "words": "生殖毒性"}, {"probability": {"variance": 0.002676, "average": 0.980977, "min": 0.681519}, "location": {"width": 743, "top": 590, "height": 36, "left": 276}, "words": "按mgm2推算(以下同),雄性大鼠经口给药剂量达最大推荐人用剂量(MRHD)的2"}, {"probability": {"variance": 9e-06, "average": 0.998149, "min": 0.986757}, "location": {"width": 780, "top": 636, "height": 30, "left": 233}, "words": "倍时,未见对生育力的影响。大鼠和家兔妊娠和哺乳期间经口给药,剂量分别为最大推荐人"}, {"probability": {"variance": 0.002199, "average": 0.987175, "min": 0.700859}, "location": {"width": 779, "top": 681, "height": 31, "left": 235}, "words": "日用剂量的2.5和4倍时,未见畸形,但可见大鼠幼仔体重减轻、死亡率增加、哺乳前5天"}, {"probability": {"variance": 0.000589, "average": 0.991871, "min": 0.883593}, "location": {"width": 779, "top": 726, "height": 31, "left": 235}, "words": "死亡幼仔数增加。动物死亡原因不明,对幼仔死亡的无影响剂量为最大推荐人日用剂量的"}, {"probability": {"variance": 0.000203, "average": 0.991179, "min": 0.962767}, "location": {"width": 64, "top": 776, "height": 24, "left": 234}, "words": "0.25倍"}, {"probability": {"variance": 0.006317, "average": 0.976093, "min": 0.546889}, "location": {"width": 717, "top": 814, "height": 31, "left": 283}, "words": "此外,在一项在雄性和雌性SD大鼠经口给子O去甲基文拉法辛琥珀酸盐30、100"}, {"probability": {"variance": 0.001271, "average": 0.988301, "min": 0.779496}, "location": {"width": 777, "top": 857, "height": 35, "left": 237}, "words": "300mg/kg,可见各剂量组出现动情周期紊乱和交配时间延长:中、高剂量组可见生育力降"}, {"probability": {"variance": 0.002779, "average": 0.98295, "min": 0.681088}, "location": {"width": 772, "top": 904, "height": 30, "left": 236}, "words": "低,高剂量组着床前死亡率增加,胎仔体重降低。100mg/kg剂量(相当于文拉法辛MRHD"}, {"probability": {"variance": 0.002483, "average": 0.981359, "min": 0.693009}, "location": {"width": 745, "top": 950, "height": 27, "left": 238}, "words": "的4.5倍)时O去甲基文拉法辛的暴露量约为文拉法辛人用剂量225mg/日时的2~3倍"}, {"probability": {"variance": 0, "average": 0.999853, "min": 0.999809}, "location": {"width": 64, "top": 1001, "height": 23, "left": 235}, "words": "致癌性"}, {"probability": {"variance": 0.004469, "average": 0.978356, "min": 0.585527}, "location": {"width": 731, "top": 1038, "height": 33, "left": 284}, "words": "小鼠经口给予文拉法辛剂量高达120mg/kg天(最大人推荐剂量的1.7倍)连续18个"}, {"probability": {"variance": 0.006103, "average": 0.973275, "min": 0.566905}, "location": {"width": 738, "top": 1079, "height": 35, "left": 239}, "words": "月,大鼠经口给子文拉法辛剂量高达120mg/kg/天连续24个月(雄性大鼠和雌性大鼠"}, {"probability": {"variance": 0.00775, "average": 0.965166, "min": 0.558768}, "location": {"width": 722, "top": 1124, "height": 32, "left": 237}, "words": "法辛血药浓度分别为最大推荐人用剂量时人血药浓度的1倍和6倍,但O去甲基文"}, {"probability": {"variance": 3.3e-05, "average": 0.997002, "min": 0.977787}, "location": {"width": 445, "top": 1171, "height": 29, "left": 240}, "words": "水平低于人体)连续24个月,未见肿瘤发生率增加"}, {"probability": {"variance": 0, "average": 0.741091, "min": 0.741091}, "location": {"width": 29, "top": 1201, "height": 34, "left": 883}, "words": "但"}, {"probability": {"variance": 0, "average": 0.972713, "min": 0.972713}, "location": {"width": 27, "top": 1190, "height": 31, "left": 915}, "words": "1"}, {"probability": {"variance": 2e-06, "average": 0.998991, "min": 0.996039}, "location": {"width": 130, "top": 1218, "height": 26, "left": 244}, "words": "【药代动力学】"}, {"probability": {"variance": 0.001325, "average": 0.988433, "min": 0.787738}, "location": {"width": 733, "top": 1258, "height": 32, "left": 285}, "words": "通过多次口服用药,文拉法辛和ODV在3天内达到稳态血药浓度。在75~450mg天的"}, {"probability": {"variance": 0.005614, "average": 0.972999, "min": 0.533387}, "location": {"width": 764, "top": 1303, "height": 32, "left": 239}, "words": "剂量范围内文拉法辛和ODV属线性药动学模型,平均稳态血浆清除率分别为1.3±0.6和0"}, {"probability": {"variance": 0.004613, "average": 0.966274, "min": 0.640833}, "location": {"width": 777, "top": 1346, "height": 36, "left": 241}, "words": "±0.2Lh/kg,表观清除半衰期分别为5±2和11±2h,表观(稳态)分布容积分别为7.5±3.7和"}, {"probability": {"variance": 0.007483, "average": 0.959137, "min": 0.644379}, "location": {"width": 745, "top": 1391, "height": 34, "left": 273}, "words": "±1.8L/kg文拉法辛和ODv在治疗血药浓度下与血浆蛋白的结合率较小,分别为27%和"}, {"probability": {"variance": 2.8e-05, "average": 0.99588, "min": 0.988352}, "location": {"width": 38, "top": 1447, "height": 19, "left": 241}, "words": "30%"}, {"probability": {"variance": 0.000152, "average": 0.987637, "min": 0.975318}, "location": {"width": 43, "top": 1490, "height": 24, "left": 243}, "words": "吸收"}, {"probability": {"variance": 0.000615, "average": 0.990207, "min": 0.882844}, "location": {"width": 737, "top": 1524, "height": 33, "left": 282}, "words": "文拉法辛容易吸收,主要在肝脏内代谢,ODV是其主要的活性代谢产物。单次口服文"}], "language": 3}